1-(carboxymethylthio)tetradecane has been researched along with Inflammation in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aukrust, P; Berge, RK; Bjørndal, B; Bohov, P; Brattelid, T; Busnelli, M; Chiesa, G; Dellera, F; Ganzetti, GS; Halvorsen, B; Holm, S; Manzini, S; Nygård, OK; Parolini, C; Sirtori, CR; Vik, R | 1 |
Berge, RK; Felberg, HS; Johansen, B; Jørgensen, KM; Laegreid, A | 1 |
Berge, K; Berge, RK; Bjørndal, B; Bohov, P; Burri, L; Svardal, A; Wergedahl, H | 1 |
Grammes, F; Rørvik, KA; Takle, H | 1 |
Aasprong, OG; Berge, RK; Bjørndal, B; Cacabelos, D; Grimstad, T; Hausken, T; Lied, GA; Nylund, K; Omdal, R; Pamplona, R; Portero-Otin, M | 1 |
Berge, RK; Gudbrandsen, OA; Kuiper, KK; Muna, ZA; Nordrehaug, JE; Salem, M | 1 |
6 other study(ies) available for 1-(carboxymethylthio)tetradecane and Inflammation
Article | Year |
---|---|
An immunomodulating fatty acid analogue targeting mitochondria exerts anti-atherosclerotic effect beyond plasma cholesterol-lowering activity in apoe(-/-) mice.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Body Weight; Cholesterol; Diet, High-Fat; Dietary Supplements; Fatty Acids; Female; Gene Expression Regulation; Immunologic Factors; Inflammation; Liver; Mice; Mitochondria; Myocardium; Oxidative Stress; RNA, Messenger; Sulfides | 2013 |
Platelet activating factor stimulates arachidonic acid release in differentiated keratinocytes via arachidonyl non-selective phospholipase A2.
Topics: Arachidonic Acid; Calcium; Cell Differentiation; Cell Line; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Group IV Phospholipases A2; Group VI Phospholipases A2; Humans; Inflammation; Inflammation Mediators; Ionophores; Isoenzymes; Keratinocytes; Organometallic Compounds; Phospholipase A2 Inhibitors; Phospholipases A2; Phospholipases A2, Secretory; Platelet Activating Factor; Signal Transduction; Sulfides | 2010 |
Tetradecylthioacetic acid increases hepatic mitochondrial β-oxidation and alters fatty acid composition in a mouse model of chronic inflammation.
Topics: Animals; Antioxidants; Chronic Disease; Diet; Fatty Acids; Female; Humans; Inflammation; Lipids; Mice; Mice, Transgenic; Mitochondria, Liver; Oxidation-Reduction; Rats; Sulfides; Tumor Necrosis Factor-alpha | 2011 |
Tetradecylthioacetic acid modulates cardiac transcription in Atlantic salmon, Salmo salar L., suffering heart and skeletal muscle inflammation.
Topics: Animals; Fish Diseases; Gene Expression Regulation; Heart; Inflammation; Muscle, Skeletal; Myocardium; Peroxisome Proliferator-Activated Receptors; Random Allocation; Salmo salar; Sulfides | 2012 |
Tetradecylthioacetic acid attenuates inflammation and has antioxidative potential during experimental colitis in rats.
Topics: Animals; Antioxidants; Colitis; Colon; Cytokines; Dextran Sulfate; Dietary Supplements; Gene Expression Regulation; Inflammation; Male; Oxidative Stress; Rats; Rats, Wistar; Sulfides | 2013 |
Dose-dependent coronary artery intimal thickening after local delivery of the anti-oxidant tetradecylthioacetic acid from stents.
Topics: Animals; Antioxidants; Arachidonic Acid; Coated Materials, Biocompatible; Coronary Restenosis; Coronary Vessels; Equipment Design; Fatty Acids; Inflammation; Random Allocation; Stents; Sulfides; Swine; Time Factors; Tunica Intima | 2007 |